Huntington, WV, Indianapolis, Ind, Greifswald, Germany, and Hanover, NH Background: T H 2 responses are implicated in asthma pathobiology. Epidemiologic studies have found a positive association between asthma and exposure to staphylococcal enterotoxins. Objective: We used a mouse model of asthma to determine whether staphylococcal enterotoxins promote T H 2 differentiation of allergen-specific CD4 conventional T (Tcon) cells and asthma by activating allergen-nonspecific regulatory T (Treg) cells to create a T H 2-polarizing cytokine milieu. Methods: Ovalbumin (OVA)-specific, staphylococcal enterotoxin A (SEA)-nonreactive naive CD4 Tcon cells were cocultured with SEA-reactive allergen-nonspecific Treg or CD4 Tcon cells in the presence of OVA and SEA. The OVA-specific CD4 T cells were then analyzed for IL-13 and IFN-g expression. SEA-activated Treg cells were analyzed for the expression of the T H 2-polarizing cytokine IL-4 and the T-cell activation markers CD69 and CD62L. For asthma induction, mice were intratracheally sensitized with OVA or cat dander extract (CDE) alone or together with SEA and then challenged with OVA or CDE. Mice were also subject to transient Treg cell depletion before sensitization with OVA plus SEA. Asthma features and T H 2 differentiation in these mice were analyzed. Results: SEA-activated Treg cells induced IL-13 but suppressed IFN-g expression in OVA-specific CD4 Tcon cells. SEAactivated Treg cells expressed IL-4, upregulated CD69, and downregulated CD62L. Sensitization with OVA plus SEA but not OVA alone induced asthma, and SEA exacerbated asthma induced by CDE. Depletion of Treg cells abolished these effects of SEA and IL-13 expression in OVA-specific T cells.
The diverse functions of CD4 T cells in immune responses are in large part mediated by different functional subsets. CD4 T cells can be categorized into regulatory T (Treg) cells and CD4 conventional T (Tcon) cells. Treg cells protect the hosts by preventing aberrant or excessive immune responses to both self and foreign antigens, and their development and functions are dependent on the transcription factor forkhead box protein 3 (Foxp3). [1] [2] [3] On the other hand, naive CD4 Tcon cells differentiate into different T H subsets following antigen stimulation to mediate diverse immune effector functions in host defense and immunopathology. 4 The T H 2 subset plays a central role in host defense against helminth infection 5 but is also implicated in allergic diseases. 6 Upon activation by antigens in the presence of T H 2-polarizing signals, naive CD4 T cells upregulate the transcription factor GATA-3 to drive T H 2 differentiation. 7 The cytokine milieu in which naive CD4 T cells are activated is a major source of the T H 2-polarizing signals. The cytokine IL-4 is a potent driver of T H 2 differentiation. It activates signal transducer and activator of transcription 6, 8 which, together with signals generated from T-cell receptors (TCRs), leads to the upregulation of GATA-3. 9, 10 Other cytokines, such as IL-33, IL-25, and thymic stromal lymphopoietin, produced outside the lymphoid tissues at the site of antigen exposure can both indirectly and directly promote T H 2 differentiation. [11] [12] [13] [14] Asthma is a pulmonary disorder characterized by recurrent and reversible airway obstruction. [15] [16] [17] It affects a large proportion of the world's population, and its incidence continues to increase in many countries, stressing the importance of prevention. 15 Although asthma is recognized as a heterogeneous group of diseases with diverse clinical manifestations and underlying causes, 18 a recent study has estimated that about half of the clinical cases are ''T H 2-high'' asthma, in which the disease pathogenesis is driven by T H 2 responses to inhaled allergens. 19 In mouse models of asthma, the T H 2 cytokine IL-13 causes airway hyperresponsiveness (AHR) 20, 21 and stimulates mucus hyperproduction, 22, 23 whereas IL-5 induces pulmonary eosinophilia. 24, 25 The T H 2 cytokines can also be produced by type 2 innate lymphoid cells. 26, 27 Nonetheless, at least in a mouse model, T H 2 cells remain the principal cell type responsible for asthma caused by allergen-specific recall response. Given the central role of T H 2 cells in asthmatic patients, how allergen-specific CD4 T cells differentiate into T H 2 cells is key to understanding asthma pathogenesis and, ultimately, the treatment and prevention of asthma. In this regard some clinical allergens, such as the house dust mite protein Der p 2, the cat dander protein Fel d 1, and the mold allergen Alternaria species extract, possess self-adjuvant activities that promote T H 2 differentiation. [29] [30] [31] In contrast, some allergens, such as the short ragweed extract and the experimental allergen ovalbumin (OVA), are considered immunologically inert, and T H 2 response to airway exposure to these allergens requires extrinsic adjuvant in the mouse model of asthma. 30 However, regardless of the immunologic properties of the allergens, not everyone exposed to allergens, even to allergens with self-adjuvant activities, develops asthma. Therefore other factors, both genetic and environmental, are required for the development of T H 2 responses to allergens that are strong enough to cause clinical disease. For prevention, environmental factors are particularly relevant because they are amenable to manipulation.
One environmental factor that can condition a person to become susceptible to asthma is exposure to staphylococcal enterotoxins (SEs). Indeed, IgE antibodies against SEs, which are an indication of prior history of SE exposure, are frequently detected in asthmatic patients. [32] [33] [34] A person can be exposed to SEs as environmental contaminants. Colonization by Staphylococcus aureus could also potentially lead to SE exposure because the majority of S aureus strains isolated from human subjects contain SE genes. 35 In fact, meta-analysis of epidemiologic studies found a statistically significant increase of S aureus colonization in asthmatic patients, 34 and a recent large-scale study of the US population confirmed a positive association between S aureus colonization and asthma between 6 and 30 years of age. 36 However, despite ample epidemiologic evidence, the immunologic basis for the positive association is poorly understood. The detection of IgE antibodies to SEs implies that SEs behave as conventional antigens/allergens to which antibody responses are generated. It has also been suggested that expansion of T cells in the lungs stimulated by the superantigen activity of SEs might contribute to asthma pathogenesis. 37 In this study we used staphylococcal enterotoxin A (SEA) to further investigate the mechanism for the immunologic role of SEs in a mouse model of allergic asthma. There have been no previous studies that specifically investigated how SEA-activated allergen nonspecific Treg cells or CD4 Tcon cells might influence T H subset differentiation of naive allergen-specific CD4 Tcon cells. Our central hypothesis is that apart from being conventional foreign antigens, SEs can act as natural adjuvants to modulate immune responses to other allergens by activating allergen nonspecific CD4 T cells to produce T H -polarizing cytokines. We further hypothesized that SE-activated allergen-nonspecific Treg cells and CD4 Tcon cells might exert different T H -polarizing effects on allergen-specific CD4 Tcon cells. Indeed, we found that SEA-activated allergen nonspecific Treg cells but not CD4 Tcon cells induced T H 2 differentiation of allergen-specific naive CD4 Tcon cells. Thus our study, together with previous epidemiologic studies, provides evidence that respiratory exposure to SEs concurrent with allergen exposure could be a common factor that confers susceptibility to asthma.
METHODS Mice
All mice used in this study except BALB/c.Thy1.1 mice, which were obtained from Dr D. Fowell, were purchased from the Jackson Laboratory (Bar Harbor, Me) and bred and maintained in local animal facilities. BALB/c.Thy1.1 is a BALB/c congenic strain that expresses Thy1.1 instead of Thy1.2 in BALB/c mice. Animal studies were performed in compliance with protocols approved by the Institutional Animal Care and Use Committees of Marshall University and Indiana University.
In vitro cell culture
Antigen-nonspecific naive CD4 Tcon or Treg cells were isolated by means of fluorescence-activated cell sorting (FACS) from BALB/c.Thy1. 1 , B6 genetic background) mice, which express 2 different transgenic OVA-specific TCRs and a GFP gene controlled by the Foxp3 promoter. 38 Antigen-presenting cells (APCs) were T and natural killer (NK) cell-depleted splenic cells irradiated with 3000 rads of x-rays.
OVA-specific naive CD4 Tcon cells were mixed with APCs and naive nonspecific Treg or CD4 Tcon cells, as indicated at 1:1:1 ratios at 1 3 10 6 cells/mL for each cell type in RPMI-1640 plus 10% FBS, 0.5 mg/mL OVA 323-339 peptide, and 5 ng/mL IL-12 (gift of Biogen, Cambridge, Mass). The cells were plated in U-bottom 96-well plates, and SEA (Toxin Technology, Sarasota, Fla) was added to the wells, as indicated at a final concentration of 5 mg/mL. On day 6 of culture, the cells were washed and then stimulated with phorbol 12-myristate 13-acetate (50 ng/mL) and ionomycin (1 mmol/L) in the presence of 2 mmol/L monensin (Sigma-Aldrich, St Louis, Mo) for 6 hours. The cells were harvested and analyzed, as previously described. 39, 40 Briefly, the cells were first stained for surface markers and then fixed and permeabilized and stained for intracellular IL-13 and IFN-g. The cells were analyzed on a FACSaria II (BD Biosciences, San Jose, Calif), and the data were processed with FlowJo software (TreeStar, Ashland, Ore).
Allergen sensitization and challenge
Mice (3-4 mice per experimental group) were intratracheally instilled with 100 mg of OVA protein (Sigma-Aldrich) or 8 mg (protein content) of cat dander extract (CDE; Greer Laboratories, Lenoir, NC) with or without 0.5 mg of SEA in 60 mL of PBS. In experiments for OVA tetramer staining of endogenous T cells, 2.5 mg of OVA 323-339 peptide was included in OVA sensitization to increase the tetramer-specific T-cell population because the tetramer is designed to detect TCRs specific for this peptide. Mice (3-4 mice per experimental group) also received intraperitoneal injection of diphtheria toxin (DT; EMD Millipore, Billerica, Mass) at 50 ng/g body weight on 2 consecutive days before allergen sensitization to deplete Treg cells in B6.Foxp3 DTR mice that express the humanized diphtheria toxin receptor (DTR) under the control of the Foxp3 promoter. 42 To reconstitute the Treg cell-depleted B6.Foxp3 DTR mice with DT-resistant Treg cells, 5 3 10 5 Treg cells isolated from B6.Foxp3.GFP mice were intravenously injected into B6.Foxp3 DTR mice 1 day before sensitization with OVA plus SEA. On day 7 after sensitization, mice were subjected to intratracheal challenge with the same doses of OVA or CDE; the challenge was repeated 2 times every other day. For Treg cell depletion before allergen challenge, mice (3 mice per experimental group) received 2 consecutive daily injections of DT before the first challenge. Three days after the last challenge, bronchoalveolar lavage fluid (BALF) was collected by flushing the lungs with 0.75 mL of PBS plus 1% FBS 3 times from anesthetized mice. Afterward, blood was drained from the lungs by means of intracardiac extraction. Lungs and mediastinal lymph nodes (MLNs) were collected, and lungs were fixed in neutral formalin. BALF cells (2 3 10 5 ) were used to prepare BALF cell smears by using a Cytospin Cytofuge. The slides were fixed and stained with DiffQuick solutions (Fisher Scientific, Waltham, Mass).
Eosinophils, macrophages, lymphocytes, and neutrophils were counted under a microscope. At least 200 cells were counted for each slide. Lung tissues were analyzed for inflammatory infiltration by means of hematoxylin and eosin (H&E) staining, and mucus production was determined by using periodic acid-Schiff (PAS) staining.
AHR assay
AHR was measured based on airway resistance and compliance, 43 which produces less variation than whole-body plethysmography. Three days after the last allergen challenge, an individual mouse was anesthetized, and a small cannula was inserted into the trachea. A total of 4 mice per experimental group were analyzed simultaneously. The mice were mechanically ventilated with the Buxco Elan Series RC instrument (200 breaths/min; 0.2-mL tidal volume) and challenged with inhalation of increasing concentrations of aerosolized solutions (10 mL) of methacholine (6.25, 12.5, 25, and 50 mg/mL; 3 minutes for each challenge). Pulmonary resistance was measured after each dose. Statistical significance of differences was determined by using the Student t test.
Tetramer analyses of OVA-specific T-cell responses
Mice sensitized with OVA protein and peptide with or without SEA were challenged with OVA protein and peptide for about 10 hours. Tetramer staining was carried out, as previously described. 44 Briefly, BALF and MLN cells from the mice were incubated with a mixture of phycoerythrin (PE)-labeled OVA-2C:IA b and OVA-3C:IA b tetramers (gifts of Dr M. Jenkins) at a final concentration of 10 nmol/L of each tetramer in complete cell culture medium supplemented with 2 mmol/L monensin (Sigma-Aldrich) at room temperature for 1 hour. After washing, the cells were surface stained with fluorochrome-conjugated antibodies against CD4, CD8, and TCRb at 48C. The cells were then fixed, permeabilized, and stained for IL-13 and IFN-g and analyzed by means of flow cytometry, as previously described. 44 
RESULTS

Regulation of OVA-specific T H differentiation by SEA-activated CD4 T cells
SEs are superantigens that can acutely activate polyclonal CD4 T cells to release cytokines, 45 which in turn could instruct T H differentiation of allergen-specific CD4 Tcon cells. To test this, we took advantage of the OVA-specific TCR transgenic mice DO11.10, which express a Vb8.2 TCR that is unresponsive to SEA. 46 OVA-specific naive CD4 Tcon cells were isolated from DO11.10.Foxp3.GFP mice (BALB/c background), and antigen-nonspecific naive Treg cells and CD4 Tcon cells were isolated from BALB/c.Thy1.1.Foxp3.GFP mice.
In mix culture experiments the OVA-specific naive CD4 Tcon cells and antigen-nonspecific naive Treg cells were stimulated with OVA 323-339 peptide and SEA, respectively, in the presence of APCs and IL-12, a major cytokine produced by APCs in response to S aureus infection. 47 After the differentiation culture, we analyzed the OVA-specific CD4 Tcon cells using intracellular staining of the T H 1 cytokine IFN-g and the T H 2 cytokine IL-13. As shown in Fig 1, A (right panel), in the presence of SEA-activated Treg cells, IFN-g expression was almost completely abolished, whereas IL-13 expression was induced, demonstrating a polarization to T H 2 differentiation of the OVA-specific CD4 Tcon cells. As expected, without Treg cells, the OVA-specific CD4 Tcon cells showed robust T H 1 differentiation (Fig 1, A, (Fig 1, B) .
Expression of IL-4 by Treg cells activated by SEA
IL-4 is the most potent polarizing cytokine for T H 2 differentiation. Naive Treg cells derived from BALB/ c.Foxp3.GFP mice were stimulated with APCs plus SEA and IL-12 to investigate whether SEA can stimulate IL-4 expression by Treg cells. After 4 days, IL-4 was detected in the culture supernatant by means of ELISA (Fig 2, A) . The IL-4 was produced by Treg cells because SEA-stimulated non-Treg cells did not produce IL-4 (Fig 2, A) . We further analyzed acute expression of IL-4 at the single-cell level based on intracellular cytokine staining. Ex vivo splenic cells of BALB/c.Foxp3.GPF mice were stimulated with SEA. Significant numbers of IL-4-producing cells (approximately 4.5%) were detected in the Treg cell population (Fig 2, B) .
To further demonstrate the activation of Treg cells by SEA, we analyzed the expression of the T-cell activation markers CD69 and CD62L, which are upregulated and downregulated after T-cell activation, respectively. Splenic Treg cells of BALB/ c.Foxp3.GFP mice intravenously injected with SEA showed upregulation of CD69 and downregulation of CD62L compared with splenic Treg cells from mice intravenously injected with PBS (Fig 2, C) .
Induction of asthma by sensitization with OVA plus SEA
The experimental allergen OVA is immunologically inert in the sense that it does not have intrinsic adjuvant activity 30 and therefore is ideal for studying the immune-modulatory or adjuvant activity of SEA in allergen sensitization. For this purpose, BALB/c mice were intratracheally sensitized with OVA alone or OVA plus SEA. One week later, the mice were intratracheally challenged with OVA or PBS 3 times and analyzed for asthma features. As shown in Fig 3, A, ) total BALF cells were detected in mice sensitized and challenged with OVA alone, and those few BALF cells were predominantly macrophages (>80%). In contrast, in mice sensitized with OVA plus SEA and challenged with OVA alone, total BALF cell counts dramatically increased (>8 3 10 5 ), and eosinophils became the dominant cell type (>60%), whereas the percentage of macrophages decreased (<40%). The increases in BALF cellularity and eosinophil counts were OVA specific because they were not observed in mice sensitized with OVA plus SEA and challenged with PBS. H&E staining of lung tissue sections also showed inflammatory infiltration only in the mice sensitized with OVA plus SEA and challenged with OVA (Fig 3, B) . PAS staining of the lung tissue sections showed massive mucus production in mice sensitized with OVA plus SEA and challenged with OVA, whereas only modest mucus staining was observed in mice sensitized and challenged with OVA alone (Fig 3, C) .
AHR to bronchial methacholine challenge is a key pathophysiologic feature of asthma. Like mucus production, heightened airway resistances to increasing doses of inhaled methacholine were detected in mice sensitized with OVA plus SEA and challenged with OVA compared with mice sensitized and challenged with OVA alone (Fig 3, D) .
Effects of transient Treg cell depletion before allergen sensitization
To further investigate whether Treg cells activated by SEA at the time of allergen exposure promote asthma pathogenesis in a mouse model of asthma, we wished to use the B6.Foxp3 DTR mice in which Treg cells can be transiently depleted by means of intraperitoneal injection of DT. 42 The cell depletion in these mice is specific for Treg cells but not other cells. 48 Because the B6.Foxp3 DTR mice are on the B6 background, we first confirmed that, like those of mice of the BALB/c background, Treg cells from mice of the B6 background also induced T H 2 differentiation of allergen-specific CD4 Tcon cells. The OTII mice express a transgenic Vb5 TCR specific for OVA that, like the DO11.10 TCR, is nonreactive to SEA. 46, 49 In vitro mix cultures were performed as in Fig 1, We then proceeded to deplete Treg cells in B6.Foxp3 DTR mice by means of 2 consecutive daily intraperitoneal injections of DT before the day of OVA plus SEA inoculation. Two DT injections deplete more than 95% of Treg cells in the B6.Foxp3 DTR but not wild-type B6 mice on day 3, and the Treg cell population recovers thereafter. 42 For comparison, a group of B6 mice also received the DT injections. B6 mice without DT injections were also included in the study. As shown in Fig 4, A, like BALB/c mice, B6 mice sensitized and challenged with OVA alone had very few inflammatory cells in the BALF, and most of these cells were macrophages. In contrast, B6 mice sensitized with OVA plus SEA and challenged with OVA showed a dramatic increase in BALF cellularity, and eosinophils became the dominant cell type in BALF. As expected, DT treatment of B6 mice before sensitization with OVA plus SEA resulted in no remarkable changes in BALF cellularity and cell differentials. In stark contrast, DT treatment of B6.Foxp3 DTR mice sensitized with OVA plus SEA and challenged with OVA abolished inflammatory infiltration in the BALF so that the BALF cellularity and cell differentials were similar to those of the B6 mice sensitized and challenged with OVA alone.
We further compared the histologic features of the DT-treated B6 and B6.Foxp3 DTR mice (Fig 4, B) . Lung sections of the DTtreated B6 mice showed substantial inflammatory infiltration, as revealed by H&E staining. Substantial mucus production was also detected in the lungs of these mice by using PAS staining. However, it must be pointed out that both mucus staining and H&E staining of inflammatory cells were weaker than those of the BALB/c mice in Fig 3, perhaps because of strain variation. Unlike in the DT-treated B6 mice, H&E and PAS staining showed little inflammatory infiltration and mucus production in the lungs of DT treated B6.Foxp3 DTR mice (Fig 4, B) . Similarly, DT-treated B6 but not B6.Foxp3 DTR mice showed increased airway resistance in response to bronchial challenge with inhaled methacholine (Fig 4, C) . In contrast to Treg cell transient depletion before sensitization, Treg cell transient depletion before challenge greatly increased BALF cellularity, and the BALF cells were codominated by both eosinophils and lymphocytes (see Fig  E4 in this article's Online Repository at www.jacionline.org). Thus SEA-activated Treg cells acted specifically in the allergen sensitization phase to promote asthma pathogenesis.
Increase in severity of CDE-induced asthma by SEA
OVA is an experimental and immunologically inert allergen. To further investigate whether SEA can also affect asthma in the J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 2 mouse model induced by a different allergen that is clinically related and has self-adjuvant activity, we used CDE 29 to induce asthma in B6.Foxp3 DTR mice. When used alone to sensitize the mice without Treg cell deletion, CDE was sufficient to induce inflammatory infiltration after CDE challenge, as judged based on high BALF cellularity (approximately 1 3 10 6 ). BALF cells in these mice consisted of a substantial number of eosinophils (>30%), but macrophages were the more abundant cell population (>65%; Fig 5, A) . When the mice were sensitized with CDE plus SEA and challenged with CDE alone, BALF cellularity increased almost 5-fold, and eosinophils became the dominant cell population (>72%) over macrophages (approximately 16%; Fig 5, A) . However, when Treg cells were transiently depleted before sensitization, the enhancement of BALF cellularity and eosinophilia was largely abolished, and these values were only slightly greater than those of mice sensitized with CDE alone (Fig 5, A) . In airway resistance assays B6 mice sensitized with CDE alone or CDE plus SEA both showed strong airway resistance in response to bronchial challenge with inhaled methacholine. Nonetheless, a significantly greater response at a high dose of 50 mg/mL methacholine was observed in mice sensitized with CDE plus SEA (Fig 5, B) .
Characteristics of early allergen-specific T-cell responses
Although T H 2 responses to allergen are believed to be critical for triggering the clinical symptoms of asthma, T cells of the in vivo immune response expressing endogenously generated allergen-specific TCRs (as opposed to transgenic TCRs) after allergen challenge have not been well characterized. To address this issue, we used a mixture of OVA-2C:I-A b and OVA-3C:I-A b tetramers, which bind to TCRs recognizing 2 distinct epitopes within the OVA 223-339 peptide, 50 to detect endogenous OVAspecific T cells in the OVA/SEA sensitization model. To increase the number of tetramer-positive T cells, we supplemented OVA protein with OVA 323-339 peptide in both sensitization and challenge. Within 8 to 9 hours after the first OVA challenge, we found that outside the MLNs, T cells were most abundant in BALF. Within the TCRb 1 cells in BALF, the OVA tetramerpositive cells were predominantly CD4 2 , although CD4 1 tetramer-positive cells were also present, and this was the case for mice either with or without Treg cell transient depletion before sensitization (Fig 6, A, middle panels) . As expected, almost all the CD4 2 tetramer-positive cells were also CD8
2 .
For detecting OVA-induced cytokine expression, we fixed and permeabilized the BALF cells immediately after tetramer and surface marker staining and then stained intracellular IFN-g and IL-13. More than a quarter of the CD4 2 tetramer-positive BALF T cells were stained positive for IL-13 in mice without Treg cell transient depletion before sensitization. IL-13
1 cells were also detected in the CD4
1 tetramer-positive BALF T cells in the same mice, although to a lesser extent (approximately 5%). IFN-g was detected in neither cell population (Fig 6, A, upper left and right panels). Negative staining of IFN-g was not due to technical failure because IFN-g was robustly stained on positive control cells. Unlike in the Treg cell-sufficient mice, in mice with Treg cell transient depletion before sensitization, neither IL-13 nor IFN-g was detected in either the CD4 -or CD4 1 tetramerpositive BALF T cells (Fig 6, A, lower left and right panels) .
MLN cells were subjected to the same analyses of tetramer staining and cytokine expression (Fig 6, C) . 
, although CD4
2 populations were also detected in both types of mice (Fig 6, C, middle panels) . Unlike in BALF, IL-13 was not detected in the tetramer-positive T cells in the MLNs (Fig 6, C, left and right panels) .
We further determined whether reconstituting the Treg cell-depleted mice with Treg cells could restore T H 2 cytokine expression. Treg cells isolated from B6.Foxp3.GFP mice were adoptively transferred to B6.Foxp3 DTR mice on the same day of the second DT injection. The mice were sensitized with OVA plus SEA and challenged with OVA, as described above. BALF cells derived from the Treg cell-constituted and nonconstituted mice were analyzed by using OVA tetramer and cytokine staining. Similar to mice untreated with DT, IL-13 expression was detected in CD4
2 OVA tetramer-positive T cells from the Treg cell-constituted and DT-treated mice but not the nonconstituted mice (Fig 7) .
DISCUSSION
Although type 2 innate lymphoid cells can also contribute to T H 2 cytokine production, T H 2 cells are the principal cells responsible for asthma caused by antigen-specific recall response to allergen challenge. 28 However, the fundamental question of why certain persons but not others have strong T H 2 responses sufficient to drive asthma pathogenesis remains unanswered. Here we showed that SEA promoted asthma caused by sensitization with the inert experimental allergen OVA, which, when administered alone, does not induce asthma but instead induces tolerance. 51, 52 SEA also exacerbated asthma caused by the clinical allergen CDE, which by itself was able to induce asthma with mild eosinophilia. In both cases the asthma-promoting activity of SEA was dependent on the activation of Treg cells by SEA at the time of allergen sensitization. Like SEA, other SEs are also superantigens and therefore should be able to activate polyclonal Treg cells and promote asthma pathogenesis.
A recent large-scale epidemiologic study found that 40.7% of asthmatic patients (vs 28.0% of nonasthmatic subjects) were serum positive for anti-SE IgE indicative of prior exposure to SEs, and there is a strong positive association between anti-SE IgE and asthma (odds ratio, 2.10). 53 However, this study measured IgE antibodies against only 3 SEs. Thus far, a total of 24 SEs (including the classical SEs, SE-like toxins, and toxic shock syndrome toxin 1) have been identified. 54 If levels of antibodies against all 24 SEs were measured, the percentage of asthmatic patients with positive results for anti-SE antibodies could be much higher. Thus although exposure to SEs might not always lead to asthma, SE exposure concurrent with allergen exposure could be a common factor for susceptibility to asthma. To dissect the immunologic mechanisms for the association between SEs and asthma, we have shown that SEA, by activating antigen-nonspecific Treg cells, promotes T H 2 and concomitantly suppresses T H 1 differentiation of OVA-specific CD4 T cells. We further demonstrated that SEA-activated Treg cells produced IL-4. Although IL-4 is by far the most potent T H 2-polarizing factor, the cellular sources of IL-4 for promoting T H 2 responses in patients with various in vivo conditions remain elusive. 55 Basophils have been shown to produce IL-4 in response to the food allergen papain, 56, 57 which can also cause occupational asthma in workers in the food-processing industry. 58 Although we could not exclude the contribution of IL-4 derived from other cell types, our studies showed that SE-activated Treg cells could be another source of IL-4 for inducing T H 2 responses to inhaled allergens that are more commonly associated with asthma than papain. It should also been pointed out that in addition to promoting T H 2 differentiation, our in vitro culture experiments showed that SEA-activated Treg cells attenuated T H 1 differentiation of OVA-specific CD4 Tcon cells. Similar function of Treg cells in modulating T H 1/T H 2 balance might explain the excessive production of T H 1 cytokines in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome caused by the loss-of-function mutation in the Foxp3 gene, hence the lack of Treg cells. 59 In fact, the ratio of GATA3 (T H 2 master regulator 7 ) to T-bet (T H 1 master regulator 60 ) was lower in Foxp3-deficient mice than in wild-type mice. 61 Furthermore, Treg cells with defects in the microRNA miR-146a and the itch E3 ubiquitin ligase cause excessive T H 1 and T H 2 responses, respectively. 62, 63 These findings suggest that there exists a regulatory network in Treg cells that controls Treg cells' abilities to modulate T H 1/ T H 2 balance.
The frequency and ability of Treg cells to produce IL-4 might explain some discrepancies in epidemiologic findings in human subjects. The positive association between asthma and S aureus colonization and/or SE exposure is most evident in adolescents and young adults, 36, 53 whereas one study found that neonatal colonization with S aureus is not associated with asthma later in life. 64 A potential explanation for the discrepancy could be the degrees of maturity of the immune system. In mice it is known that there is a lack or paucity of Treg cells in neonates. 35, 36 In human subjects a general lack of Treg cells might not be a feature of the neonatal immune system, but there are clear variations of Treg cell frequencies among subjects. In fact, higher frequencies of Treg cells in neonates are positively associated with asthma in later life, 65 which is consistent with our finding that SE-activated Treg cells promote allergen-specific T H 2 differentiation in the sensitization phase. Studies of the ability of human Treg cells to produce IL-4 on stimulation by SEs will further clarify the role of Treg cells in asthmatic patients.
The throat is the primary site of S aureus colonization in the respiratory tract. 66, 67 Therefore the trachea and lower airways are natural sites of exposure to SEs excreted by the throatcolonizing bacteria or inhaled as environmental contaminants. Our studies demonstrated that a single intratracheal inoculation of allergen plus SEA was an effective model of allergen sensitization for asthma. The 70% lethal dose of SEA in mice is 0.3 mg/g body weight, 68 therefore the SEA dose used in this study for asthma induction (approximately 0.025 mg/g body weight) is a safe dose. The lethal dose of SEA in human subjects or primates has not been determined, and there is also a lack of information on the precise levels of SEA resulting from S aureus colonization or sepsis. In addition, human T cells are much more sensitive to SEs than mouse T cells. Therefore it is difficult to draw a comparison between our experimental dose of SEA and exposure levels in human subjects. Nonetheless, using our mouse model and OVA:IA b tetramers, we unveiled several unique features of early allergenspecific T-cell responses in the airways and MLNs. Within less than 10 hours of the first allergen challenge, OVA-specific T cells in BALF were dominated by the CD4 2 population while significant numbers of CD4 1 T cells were also detected. Unlike in the BALF, in the MLNs CD4 1 T cells were the dominant OVA-specific T cells, although OVA-specific CD4 2 T cells were also found. Whether the CD4 2 T cells in the BALF, as well as in the MLNs, were derived from CD4 1 T cells that had lost CD4 expression on allergen stimulation or were originally CD4 2 remains a question. Nonetheless, this finding suggests that targeting CD4 might not be an effective strategy for mitigating allergen-specific T-cell responses in asthmatic patients.
OVA-stimulated IL-13 expression was detected mostly in the OVA-specific CD4 2 T-cell population and, to a lesser extent, in the CD4 In the first alternative, we assume that BALF T cells originate from MLNs and that priming of allergen-specific T cells in the MLNs occurs over a period of time. Because release of cytokines, such as IL-4, by SEA-activated Treg cells is a transient event, only the early wave or waves of allergen-specific T cells are subject to T H 2 polarization by the SEA-activated Treg cells. Such early activated T cells are more likely to exit the MLNs and migrate to the airways. In contrast, T cells remaining in the MLNs are likely those primed at later time points when the T H 2-polarizing effect of SEA-activated Treg cells has dissipated so that these T cells remain undifferentiated and therefore do not produce IL-13.
In the second alternative we suspect that BALF T cells are primed in situ and preferentially differentiate into T H 2 cells because of direct exposure of antigen-nonspecific Treg cells to SEA. In support of this scenario, Constant et al 69 have shown that antigen-loaded dendritic cells indeed can stay in the lung and prime T cells in situ without the involvement of lymph nodes and the spleen.
In conclusion, we have presented experimental evidence that SEs act as natural adjuvants by activating allergen-nonspecific Treg cells to promote T H 2 responses to allergens, thereby promoting asthma pathogenesis in a mouse model of asthma. These findings suggest that attenuating the activation of Treg cells by SEs in the allergen sensitization phase could help prevent asthma and possibly other allergic diseases. 
